A single dose of ketorolac during surgery may suppress cancer relapse : something for nothing?

Forget, Patrice
(2013)

Files

ForgetThesis.pdf
  • Open Access
  • Adobe PDF
  • 2.1 MB
Download

Details

Authors
  • Forget, PatriceUCLouvain
    author
Supervisors
De Kock, Marc
Abstract
Growth of tumors can accelerate during the peri-operative period. Understanding the complex role of inflammation and its consequences, positive and deleterious could lead to identify inflammatory-related biomarkers and therapeutic opportunities. In the works described here, we show how the neutrophil:lymphocyte ratio can be used as a prognostic factor before breast, lung and kidney cancer surgery, and how and why the intraoperative use of a single dose of ketorolac, a non-steroidal anti-inflammatory drug, has been identified as a promising way to prevent, at least some, postoperative cancer relapses.
Affiliations
  • Institution iconUCLouvain(SLuc) Service d'anesthésiologie
  • Institution iconUCLouvainSSS/IREC - Institut de recherche expérimentale et clinique

Citations

  • APA
  • Chicago
  • FWB

Forget, P. (2013). A single dose of ketorolac during surgery may suppress cancer relapse : something for nothing? https://hdl.handle.net/2078.5/26113